Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

Leukemia. 2020 Aug;34(8):2260-2261. doi: 10.1038/s41375-020-0904-z. Epub 2020 Jun 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Betacoronavirus / isolation & purification*
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Disease Management
  • Humans
  • Infection Control / methods*
  • Italy / epidemiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / virology
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • Practice Guidelines as Topic / standards*
  • Protein Kinase Inhibitors / therapeutic use
  • SARS-CoV-2
  • Surveys and Questionnaires
  • Telemedicine*
  • Time-to-Treatment / statistics & numerical data

Substances

  • Protein Kinase Inhibitors